Johnson and Johnson, US government extend settlement to help next phase of COVID-19 immunization R&D

Overview

• Post By : Kumar Jeetendra


• Source: Reuters


• Date: 15 Nov,2020

Johnson & Johnson and the US Department of Health and Human Services have expanded an agreement to support the next phase of COVID-19 vaccine candidate research and development, the company said on Saturday.

Under the agreement the company will commit approximately $604 million and the HHS Department’s Biomedical Advanced Research and Development Authority will commit approximately $454 million to support the Stage 3 ENSEMBLE trial assessing Janssen’s investigational COVID-19 vaccine candidate as a single dose in up to 60,000 volunteers worldwide, the company said in a statement.